Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 31;3(5):e002689.
doi: 10.1136/bmjopen-2013-002689.

Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort

Nayantara Coelho-Prabhu  1 , Nilay D Shah, Holly Van Houten, Patrick S Kamath, Todd H Baron
Affiliations

Endoscopic retrograde cholangiopancreatography: utilisation and outcomes in a 10-year population-based cohort

Nayantara Coelho-Prabhu et al. BMJ Open. .

Abstract

Objective: To determine utilisation of endoscopic retrograde cholangiopancreatography (ERCP); incidence of inpatient admissions for complications occurring within 30 days of ERCP and risk factors for procedural-related complications, in a population-based study.

Design: Retrospective cohort study.

Setting: Olmsted County, Minnesota.

Participants: All adult residents of Olmsted County, Minnesota, who underwent ERCP from 1997 to 2006.

Interventions: Diagnostic and therapeutic ERCPs were assessed.

Primary and secondary outcome measures: Patient and procedural characteristics and complications within 30 days; and rates of ERCP utilisation and unplanned admissions and risk factors for admissions.

Results: In 10 years, 1072 ERCPs were performed on 827 individual patients. Average utilisation of ERCP was 83.1 ERCPs/100 000 persons/year, with an increase from 58 to 104.8 ERCPs/100 000 persons/year over time, driven by increases in therapeutic procedures. Within 30 days after 236 procedures, 62 admissions were definitely related to the index ERCP. The complication rate was 5.3%, including pancreatitis (26, 2.4%), infection/cholangitis (16, 1.5%), bleeding (15, 1.4%) and perforation (4, 0.37%). 30-day mortality was 2.4%, none of which was directly related to the ERCP or complications thereof. Risk factors identified through multivariate analysis to be associated with adverse events included: age <45 years (p=0.0498); body mass index ≥35 (p=0.0024); pancreatic duct cannulation (p=0.0026); outpatient procedure (p<0.0001); intraprocedure sphincterotomy bleeding (p<0.0001); difficulty grade (p=0.115) and patient's first ERCP (p=0.0394).

Limitations: Retrospective study.

Conclusions: Population utilisation of ERCP rose during the study period, specifically in therapeutic procedures. Admissions within 30 days of ERCP are common but often unrelated. Complications of ERCP remain infrequent and deaths quite unusual.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Utilisation characteristics of endoscopic retrograde cholangiopancreatography, endoscopic ultrasound and MR cholangiopancreatography in Olmsted County over a 10-year period.
See this image and copyright information in PMC

References

    1. McCune WS, Shorb PE, Moscovitz H. Endoscopic cannulation of the ampulla of vater: a preliminary report. Ann Surg 1968;167:752–6. - PMC - PubMed
    1. Adler DG, Baron TH, Davila RE, et al. ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005;62:1–8. - PubMed
    1. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781–8. - PubMed
    1. Bodger K, Bowering K, Sarkar S, et al. All-cause mortality after first ERCP in England: clinically guided analysis of hospital episode statistics with linkage to registry of death. Gastrointest Endosc 2011;74:825–33. - PubMed
    1. Christensen M, Matzen P, Schulze S, et al. Complications of ERCP: a prospective study. Gastrointest Endosc 2004;60:721–31. - PubMed

LinkOut - more resources